We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M Turnover 27.89%
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$14.3M
Cap. Flow
+$10.4M
Cap. Flow %
4.51%
Top 10 Hldgs %
31.83%
Holding
146
New
35
Increased
57
Reduced
31
Closed
6
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.19M
2
TGT icon
Target
TGT
+$645K
3
XLNX
Xilinx Inc
XLNX
+$524K
4
FISV icon
Fiserv Inc
FISV
+$483K
5
IPGP icon
IPG Photonics
IPGP
+$386K

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$595K
2
SYK icon
Stryker
SYK
+$258K
3
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$228K
4
GIS icon
General Mills
GIS
+$227K
5
COL
Rockwell Collins
COL
+$216K

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Healthcare 23.62%
3 Industrials 17.11%
4 Energy 10.93%
5 Miscellaneous 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NSC icon
51
Norfolk Southern
NSC
$72.7B
$583K 0.25%
6,000
-528
-8% -$49K
2013 Q2
3 quarters
UNFI icon
52
United Natural Foods
UNFI
$2.88B
$572K 0.25%
8,072
+265
+3% +$18.9K
2013 Q2
3 quarters
GSK icon
53
GSK
GSK
$95.9B
$530K 0.23%
7,920
+3,376
+74% +$228K
2013 Q4
1 quarter
BMY icon
54
Bristol-Myers Squibb
BMY
$121B
$520K 0.22%
10,007
-285
-3% -$15.2K
2013 Q2
3 quarters
ALNY icon
55
Alnylam Pharmaceuticals
ALNY
$30B
$517K 0.22%
7,690
-7,685
-50% -$595K
2013 Q2
3 quarters
GLW icon
56
Corning
GLW
$121B
$513K 0.22%
24,630
-800
-3% -$15K
2013 Q2
3 quarters
COST icon
57
Costco
COST
$435B
$481K 0.21%
4,306
+185
+4% +$21.2K
2013 Q2
3 quarters
STT icon
58
State Street
STT
$45.8B
$432K 0.19%
6,210
-1,000
-14% -$69.2K
2013 Q2
3 quarters
COP icon
59
ConocoPhillips
COP
$171B
$418K 0.18%
5,935
– –
2013 Q2
3 quarters
GPC icon
60
Genuine Parts
GPC
$18.1B
$414K 0.18%
4,765
+365
+8% +$30.8K
2013 Q2
3 quarters
RPM icon
61
RPM International
RPM
$12.5B
$414K 0.18%
9,895
+685
+7% +$28.2K
2013 Q2
3 quarters
JPM icon
62
JPMorgan Chase
JPM
$890B
$402K 0.17%
6,629
+1,215
+22% +$70.2K
2013 Q2
3 quarters
NBL
63
DELISTED
Noble Energy, Inc.
NBL
$399K 0.17%
5,620
+361
+7% +$23.9K
2013 Q2
3 quarters
ANSS icon
64
DELISTED
Ansys
ANSS
$375K 0.16%
4,875
+350
+8% +$28.3K
2013 Q2
3 quarters
CTSH icon
65
Cognizant
CTSH
$28.1B
$368K 0.16%
7,270
-350
-5% -$17.5K
2013 Q2
3 quarters
LECO icon
66
Lincoln Electric
LECO
$14.1B
$367K 0.16%
5,090
+270
+6% +$19.4K
2013 Q2
3 quarters
PCP
67
DELISTED
PRECISION CASTPARTS CORP
PCP
$367K 0.16%
1,450
+80
+6% +$20.7K
2013 Q2
3 quarters
NTRS icon
68
Northern Trust
NTRS
$29.8B
$344K 0.15%
5,245
+375
+8% +$23.3K
2013 Q2
3 quarters
SJM icon
69
J.M. Smucker
SJM
$13B
$343K 0.15%
3,530
-25
-0.7% -$2.43K
2013 Q2
3 quarters
NEOG icon
70
Neogen
NEOG
$2.65B
$336K 0.15%
19,936
-2,040
-9% -$33.3K
2013 Q2
3 quarters
HES icon
71
DELISTED
Hess
HES
$332K 0.14%
4,000
– –
2013 Q2
3 quarters
SCL icon
72
Stepan Co
SCL
$1.41B
$326K 0.14%
5,050
+405
+9% +$25.4K
2013 Q2
3 quarters
WFM
73
DELISTED
Whole Foods Market Inc
WFM
$325K 0.14%
6,400
– –
2013 Q2
3 quarters
PFE icon
74
Pfizer
PFE
$166B
$309K 0.13%
10,129
-1,775
-15% -$52.9K
2013 Q2
3 quarters
TROW icon
75
T. Rowe Price
TROW
$21.3B
$307K 0.13%
3,725
+360
+11% +$29.2K
2013 Q2
3 quarters
1 2
3
4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q1 2014 Portfolio in Review

As of Q1 2014, Michael B. Elefante held 146 positions worth $231M, up 6.6% from $217M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael B. Elefante deployed $10.4M of net new capital in Q1 2014, opening 35 new positions and adding to 57 existing holdings. Its largest new stake was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $595K trimmed.

  • Michael B. Elefante's largest Q1 2014 buy was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.
  • Michael B. Elefante added most to Qualcomm in Q1 2014, an estimated $1.19M increase.
  • Michael B. Elefante's biggest Q1 2014 reduction was Alnylam Pharmaceuticals, cutting an estimated $595K.
  • Michael B. Elefante fully exited Stryker in Q1 2014, selling an estimated $258K.
  • Michael B. Elefante's ten largest holdings make up 32% of its $231M portfolio in Q1 2014.
  • Michael B. Elefante opened 35 new positions and closed 6 in Q1 2014.
  • Michael B. Elefante's portfolio value rose 6.6% quarter-over-quarter to $231M.

Based on Michael B. Elefante's 13F filing for Q1 2014, filed 29 May 2014.